Vivani Medical (NASDAQ:VANI – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.01), Zacks reports.
Vivani Medical Trading Down 2.9 %
VANI opened at $1.02 on Wednesday. Vivani Medical has a 1 year low of $1.00 and a 1 year high of $2.22. The stock’s 50 day simple moving average is $1.13 and its 200-day simple moving average is $1.21. The stock has a market cap of $60.42 million, a PE ratio of -2.27 and a beta of 3.20.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reaffirmed a “buy” rating and set a $4.00 price target on shares of Vivani Medical in a research note on Wednesday, March 26th.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Stories
- Five stocks we like better than Vivani Medical
- Why Are Stock Sectors Important to Successful Investing?
- Will 2025 Be the Year the Energy Sector Finally Breaks Out?
- What Are Some of the Best Large-Cap Stocks to Buy?
- NextEra Energy Stock Sees Spike in Bullish Call Activity
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Top 3 Stocks Mega Investors Are Buying Now
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
